Abridge
The one conversation that matters.
Pittsburgh, PA, US
Abridge is an AI-powered platform that automatically generates structured clinical notes from patient-physician conversations. Using generative AI, it listens ambiently to the conversation and creates a real-time, accurate summary in the required format for the electronic health record (EHR), saving doctors hours of administrative work each day.
Source: Digital.Health
Digital.Health provided this information. To learn more and get deep data on digital health companies, please visit them here.
Visit Digital.Health →
How We Help
Why it matters
Abridge addresses documentation burden, clinician burnout, note quality, and emerging revenue-cycle intelligence at the clinical conversation layer.
Products
Abridge ambient AI platform
AI for clinical conversations and documentation across care settings.
Learn more →What the company reports
Claims are attributed to their source and not independently verified unless noted.
Who it's for
Founders
Via Digital.Health
Shivdev Rao, MD
Founder / CEO
Problem Statement
Physician burnout is a crisis, largely driven by the overwhelming burden of clinical documentation. Doctors spend more time on paperwork than with patients, leading to exhaustion, errors, and a decline in the quality of care. Existing solutions are often clunky and don't fit naturally into the patient-physician conversation.
Core Technology
Generative AI for Clinical Documentation
Key Differentiators
Focus on ambient, conversational AI that integrates seamlessly into the clinical workflow. Proprietary dataset from over 200,000 clinical encounters. Real-time note generation and structuring. Backed by major health systems and top-tier VCs.
Clinical Focus
Primary Care, Specialty Care
Target Customers
Hospitals, Health Systems, large physician groups.
Product Stage
GA
Company Info
- Business Model
- B2B2C
- Founded
- 2018
- Total Funding
- 212,500,000
- Website
- www.abridge.com/
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Abridge's technology is built on a proprietary dataset from more than 200,000 clinical encounters. Their AI is continuously trained and evaluated by medical professionals to ensure accuracy. They have demonstrated a 99%+ accuracy rate in identifying medical terms and medications. A study published in the New England Journal of Medicine Catalyst showed Abridge saved clinicians over 3 hours per week on average.
IP Protection
Patents Pending
MedStartr Index Score
?What do you think of Abridge?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.